Speciality European Pharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSpeciality European Pharma

Speciality European Pharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Plenaxis	Abarelix	2003-11-25		—

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

prostatic neoplasms

,

Aglatimagene besadenovec

renal cell carcinoma

,

colonic neoplasms

,

,

urethral neoplasms

,

transitional cell carcinoma

,

neuroendocrine carcinoma

,

,

,

non-small-cell lung carcinoma

,

urinary bladder neoplasms

,

urologic neoplasms

,

small cell lung carcinoma

,

breast neoplasms

,

,

,

neuroendocrine tumors

,

ovarian neoplasms

,

uterine cervical neoplasms

,

small cell carcinoma

,

,

triple negative breast neoplasms

,

colorectal neoplasms

,

hepatocellular carcinoma

,

liver neoplasms

,

squamous cell carcinoma

,

,

disease progression

,

squamous cell carcinoma of head and neck

,

,

pancreatic neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

head and neck neoplasms

,

esophageal neoplasms

,

ovarian epithelial carcinoma

,

neoplasm metastasis

,

hypersensitivity

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

prostatic hyperplasia

,

,

disease susceptibility

healthy volunteers/patients

,

,

pheochromocytoma

,

neuroendocrine tumors

,

,

meningeal carcinomatosis

,

,

laryngeal neoplasms

,

pancreatic ductal carcinoma

,

head and neck neoplasms

,

squamous cell neoplasms

,

transitional cell carcinoma

,

fallopian tube neoplasms

,

small cell carcinoma

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

dna repair-deficiency disorders

,

urinary bladder neoplasms

,

salivary gland neoplasms

,

,

,

radiation effects

,

germ cell and embryonal neoplasms

,

peritoneal neoplasms

,

,

pleural effusion

,

malignant pleural effusion

,

,

,

breast neoplasms

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

prostatic neoplasms

,

,

,

,

small cell lung carcinoma

,

,

,

,

,

rheumatoid arthritis

,

castration-resistant prostatic neoplasms

,

triple negative breast neoplasms

,

ovarian neoplasms

,

,

major depressive disorder

,

depressive disorder

,

,

gastroesophageal reflux

,

peptic esophagitis

,

,

colorectal neoplasms

,

,

squamous cell carcinoma

,

endometrial neoplasms

,

neoplasm metastasis

,

,

,

squamous cell carcinoma of head and neck

,

renal cell carcinoma

,

urologic neoplasms

,

ovarian epithelial carcinoma

,

neoplasms by site

,

,

,

kidney diseases

,

,

cardiovascular diseases

,

pancreatic neoplasms

,

hypersensitivity

,

stomach neoplasms

,

sickle cell anemia

,

brain neoplasms

,

,

,

opioid-induced constipation

,

hypercholesterolemia

,

hepatocellular carcinoma

,

liver neoplasms

,

hereditary breast and ovarian cancer syndrome

,

,

chronic renal insufficiency

,

,

,

kidney neoplasms

,

,

zollinger-ellison syndrome

,

,

peptic ulcer hemorrhage

,

,

,

chronic obstructive pulmonary disease

,

obstructive lung diseases

,

,

anxiety disorders

,

,

,

,

venous thrombosis

,

pulmonary embolism

,

,

plexiform neurofibroma

,

neurofibromatosis 1

,

neurofibromatoses

,

,

unknown primary neoplasms

,

respiratory insufficiency

,

myocardial infarction

,

coronary artery disease

,

biliary tract neoplasms

,

respiratory syncytial virus infections

,

non-small-cell lung carcinoma

,

,

respiratory tract diseases

,

respiratory tract neoplasms

,

bronchogenic carcinoma

,

thoracic neoplasms

,

bronchial neoplasms

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use